The Continuing Challenges of Leprosy, Clinical Microbiology Reviews, vol.19, issue.2, pp.338-381, 2006. ,
DOI : 10.1128/CMR.19.2.338-381.2006
The impact of leprosy control on the transmission of M. leprae: is elimination being attained?, Lepr Rev, vol.78, pp.330-337, 2007. ,
Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea, Journal of Infection, vol.50, issue.1, pp.6-11, 2005. ,
DOI : 10.1016/j.jinf.2004.03.012
The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines, Lepr Rev, vol.78, pp.343-352, 2007. ,
Primary and secondary dapsone resistance of M. leprae in Martinique, Int J Lepr Other Mycobact Dis, vol.55, pp.672-679, 1980. ,
Primary dapsone resistance in China, Lepr Rev, vol.60, pp.263-266, 1989. ,
Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin, Int J Lepr Other Mycobact Dis, vol.57, pp.607-614, 1989. ,
Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy, Leprosy Review, vol.71, pp.81-87, 2000. ,
DOI : 10.5935/0305-7518.20000074
Molecular Detection of Rifampin and Ofloxacin Resistance for Patients Who Experience Relapse of Multibacillary Leprosy, Clin Infect Dis, vol.34, pp.39-45, 2002. ,
Powerful Bactericidal Activity of Moxifloxacin in Human Leprosy, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.3113-3117, 2008. ,
DOI : 10.1128/AAC.01162-07
Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae, The Lancet, vol.349, issue.9045, pp.103-104, 1997. ,
DOI : 10.1016/S0140-6736(05)60888-4
Multidrug Resistant Mycobacterium leprae from Patients with Leprosy, Antimicrobial Agents and Chemotherapy, vol.45, issue.12, pp.3635-3639, 2001. ,
DOI : 10.1128/AAC.45.12.3635-3639.2001
from leprosy patients using Touch-Down (TD) PCR, FEMS Immunology & Medical Microbiology, vol.36, issue.1-2, pp.27-32, 2003. ,
DOI : 10.1016/S0928-8244(03)00038-5
Are All the DNA Gyrase Mutations Found in Mycobacterium leprae Clinical Strains Involved in Resistance to Fluoroquinolones?, Antimicrobial Agents and Chemotherapy, vol.52, issue.2, pp.745-747, 2008. ,
DOI : 10.1128/AAC.01095-07
Impact of Amino Acid Substitutions in B Subunit of DNA Gyrase in Mycobacterium leprae on Fluoroquinolone Resistance, PLoS Neglected Tropical Diseases, vol.6, issue.10, p.1838, 2012. ,
DOI : 10.1371/journal.pntd.0001838.s004
Amino Acid Substitutions at Position 95 in GyrA Can Add Fluoroquinolone Resistance to Mycobacterium leprae, Antimicrobial Agents and Chemotherapy, vol.56, issue.2, pp.697-702, 2012. ,
DOI : 10.1128/AAC.05890-11
A Second Case of Multidrug-resistant Mycobacterium leprae Isolated from a Japanese Patient with Relapsed Lepromatous Leprosy, International Journal of Leprosy and Other Mycobacterial Diseases, vol.71, issue.3, p.240, 2003. ,
DOI : 10.1489/1544-581X(2003)71<240:ASCOMM>2.0.CO;2
Drug and Multidrug Resistance among Mycobacterium leprae Isolates from Brazilian Relapsed Leprosy Patients, Journal of Clinical Microbiology, vol.50, issue.6, pp.1912-1917, 2012. ,
DOI : 10.1128/JCM.06561-11
The ''proportional bactericidal test'': a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice, Lepr Rev, vol.49, pp.7-15, 1978. ,
A method for counting acid-fast bacteria, Int J Lepr Other Mycobact Dis, vol.36, pp.78-82, 1968. ,
Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae, Int J Lepr Other Mycobact Dis, vol.50, pp.96-101, 1982. ,
A rapid method for the detection of potentially viable Mycobacterium leprae in human biopsies: a novel application of PCR, FEMS Microbiol Lett, vol.53, pp.305-309, 1989. ,
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin, Int J Lepr Other Mycobact Dis, vol.68, pp.452-455, 2000. ,
Bactericidal Activities of HMR 3647, Moxifloxacin, and Rifapentine against Mycobacterium leprae in Mice, Antimicrobial Agents and Chemotherapy, vol.44, issue.10, pp.2919-2921, 2000. ,
DOI : 10.1128/AAC.44.10.2919-2921.2000
Bactericidal Activities of R207910 and Other Newer Antimicrobial Agents against Mycobacterium leprae in Mice, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1558-1560, 2006. ,
DOI : 10.1128/AAC.50.4.1558-1560.2006
Expression and Purification of an Active Form of the Mycobacterium leprae DNA Gyrase and Its Inhibition by Quinolones, Antimicrobial Agents and Chemotherapy, vol.51, issue.5, pp.1643-1648, 2007. ,
DOI : 10.1128/AAC.01282-06
Activities of Garenoxacin against Quinolone-Resistant Streptococcus pneumoniae Strains In Vitro and in a Mouse Pneumonia Model, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.765-773, 2004. ,
DOI : 10.1128/AAC.48.3.765-773.2004
In Vitro Activity of Garenoxacin against Streptococcus pneumoniae Mutants with Characterized Resistance Mechanisms, Antimicrobial Agents and Chemotherapy, vol.53, issue.8, pp.3572-3575, 2009. ,
DOI : 10.1128/AAC.00176-09
Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA Mutation, Antimicrobial Agents and Chemotherapy, vol.53, issue.4, pp.1720-1721, 2009. ,
DOI : 10.1128/AAC.00049-09
In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae, International Journal of Antimicrobial Agents, vol.39, issue.2, pp.163-167, 2012. ,
DOI : 10.1016/j.ijantimicag.2011.09.021
In vitro and in vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae, Japanese journal of leprosy, vol.76, issue.1, pp.11-17, 2007. ,
DOI : 10.5025/hansen.76.11
Questions and answers on the withdrawal of the marketing application for Garenoxain Mesylate, 2007. ,
Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model, Antimicrobial Agents and Chemotherapy, vol.54, issue.11, pp.4765-4771, 2010. ,
DOI : 10.1128/AAC.00968-10
Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of Mycobacterium tuberculosis Resistant to Fluoroquinolones, Antimicrobial Agents and Chemotherapy, vol.50, issue.12, pp.4170-4173, 2006. ,
DOI : 10.1128/AAC.00944-06
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice, Antimicrob Agents Chemother, vol.40, pp.393-399, 1996. ,
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients, Antimicrob Agents Chemother, vol.40, pp.2137-2141, 1996. ,
Ofloxacin population pharmacokinetics in patients with tuberculosis, Int J Tuberc Lung Dis, vol.6, pp.503-509, 2002. ,
Activity of ofloxacin against Mycobacterium leprae in the mouse, Int J Lepr Other Mycobact Dis, vol.56, pp.259-264, 1988. ,
Comparative Pharmacokinetics of Ciprofloxacin, Gatifloxacin, Grepafloxacin, Levofloxacin, Trovafloxacin, and Moxifloxacin after Single Oral Administration in Healthy Volunteers, Antimicrobial Agents and Chemotherapy, vol.44, issue.10, pp.2600-2603, 2000. ,
DOI : 10.1128/AAC.44.10.2600-2603.2000
Pharmacodynamics of the New Des-F(6)-Quinolone Garenoxacin in a Murine Thigh Infection Model, Antimicrobial Agents and Chemotherapy, vol.47, issue.12, pp.3935-3941, 2003. ,
DOI : 10.1128/AAC.47.12.3935-3941.2003
Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy Subjects, Antimicrobial Agents and Chemotherapy, vol.47, issue.7, pp.2256-2263, 2003. ,
DOI : 10.1128/AAC.47.7.2256-2263.2003
The pharmacokinetics of clarithromycin and its 14-OH metabolite, Journal of Hospital Infection, vol.19, pp.29-37, 1991. ,
DOI : 10.1016/0195-6701(91)90215-T
Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia, Antimicrobial Agents and Chemotherapy, vol.46, issue.5, pp.1425-1434, 2002. ,
DOI : 10.1128/AAC.46.5.1425-1434.2002
Detection of Antibiotic Resistance in Leprosy Using GenoType LepraeDR, a Novel Ready-To-Use Molecular Test, PLoS Neglected Tropical Diseases, vol.6, issue.7, p.1739, 2012. ,
DOI : 10.1371/journal.pntd.0001739.t003
Possible Mode of Emergence for Drug-Resistant Leprosy Is Revealed by an Analysis of Samples from Mexico, Jpn J Infect Dis, vol.63, pp.412-416, 2010. ,